Early Day Motion·EDM 665

NEUROBLASTOMA TREATMENT

4 November 201330 Signatures

Motion Text

That this House recognises that neuroblastoma affects around 100 children a year in the UK; further recognises that children with this type of cancer have an 80 to 95 per cent chance of relapsing at any time until they reach the age of 20; understands that the best chance of survival is by using a new treatment called Radioimmunosorbent Test (RIST); acknowledges that those suffering from the disease have to travel abroad for RIST treatment because none is available in the UK; notes that the cost of RIST treatment can be as high as £300,000; and calls on the Government to consider ways in which RIST treatment can be made available in the UK.